{"id":15253,"date":"2025-10-14T15:31:03","date_gmt":"2025-10-14T13:31:03","guid":{"rendered":"https:\/\/semmelweis.hu\/pharmacology\/?page_id=15253"},"modified":"2026-02-09T13:13:38","modified_gmt":"2026-02-09T12:13:38","slug":"exploring-the-role-of-the-glycinergic-system-in-the-development-of-opioid-analgesic-tolerance","status":"publish","type":"page","link":"https:\/\/semmelweis.hu\/pharmacology\/en\/research\/grants\/exploring-the-role-of-the-glycinergic-system-in-the-development-of-opioid-analgesic-tolerance\/","title":{"rendered":"Exploring the role of the glycinergic system in the development of opioid analgesic tolerance"},"content":{"rendered":"<div class=\"lead\" style=\"text-align: center\">Exploring the role of the glycinergic system in the development of opioid analgesic tolerance<\/div>\n<div>\u00a0<\/div>\n<table style=\"border-collapse: collapse;width: 100%\">\n<tbody>\n<tr>\n<td style=\"width: 50%\">Grant:<\/td>\n<td style=\"width: 50%\">OTKA-FK_ZF_2021<\/td>\n<\/tr>\n<tr>\n<td style=\"width: 50%\">Amount of support:<\/td>\n<td style=\"width: 50%\">39.942.000 HUF<\/td>\n<\/tr>\n<tr>\n<td style=\"width: 50%\">Duration:<\/td>\n<td style=\"width: 50%\">2021. 09. 01. \u2013 2026. 04. 30.<\/td>\n<\/tr>\n<tr>\n<td style=\"width: 50%\">Principal investigator:<\/td>\n<td style=\"width: 50%\">Ferenc Z\u00e1dor, MD, PhD<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p>&nbsp;<\/p>\n<p><strong>Summary<\/strong><\/p>\n<p>Glycine transporters (GlyTs) 1 and 2 are involved in the regulation of synaptic glycine levels and are implicated in nociception; however, their role in the development of opioid analgesic tolerance remains unexplored. The project aims to investigate the molecular mechanisms of GlyTs regarding morphine analgesic tolerance upon chronic treatment with morphine in rats. To this end, the following experiments will be carried out: measuring the effects of morphine per se or in combination with GlyT inhibitors on the development of morphine tolerance and the function of mu opioid receptors, a key player in opioid analgesic tolerance; and deciphering the role of N-methyl-D-aspartate receptors and PKCgamma, which negatively influence MOR function at the level of the spinal dorsal horn, an area crucial for understanding opioid analgesic tolerance. By elucidating the glycinergic system&#8217;s status and the mediating roles of NMDAR and PKCgamma, this project can fill a significant gap in our understanding of opioid tolerance.<\/p>\n<p><strong>Participating leading researchers, collaboration partners, universities, companies <\/strong><\/p>\n<p>Ferenc Z\u00e1dor serves as the principal investigator for the proposed project, bringing extensive experience in opioid receptor pharmacology. He is supported by senior researchers, including Mahmoud Al-Khrasani (head of the research group) and Korn\u00e9l Kir\u00e1ly, both experts in opioid analgesic tolerance and pharmacological experiments. L\u00e1szl\u00f3 G. H\u00e1rsing contributes knowledge of glycine transporters (GlyTs) and their inhibitors. Collaborators include Tam\u00e1s T\u00e1bi (head of the Department of Pharmacodynamics, Semmelweis University), S\u00e1ndor Benyhe (head of the Laboratory of Opioid Research, Biological Research Centre, Szeged, Hungary), and Zita Puskar and Mark Kozsurek from the Janos Szentagothai Laboratory, Semmelweis University.<\/p>\n<p><strong>Applied methods and tools <\/strong><\/p>\n<p>The rat tail-flick pain model assay, rat rotarod, unrestrained whole-body plethysmography, ADP-GloTM luminescent kinase assay system (PKC\u03b3 Kinase Enzyme System), Western blot, Capillary electrophoresis-laser induced fluorescence, immunohistochemistry, receptor binding experiments, and whole-cell patch clamp system.<\/p>\n<p><strong>Pictures<\/strong><\/p>\n\r\n        [slb_exclude]\r\n        <div class=\"row galeria-wrapper mx-0 h-auto\">\r\n            <div class=\"col-9 pl-0 pr-2\">\r\n            <span class=\"gallery-item frame\">\r\n\t\t\t\t<div class=\"galeria-left-img\"><a href=\"https:\/\/semmelweis.hu\/pharmacology\/files\/2025\/10\/otka-fk-zf1-scaled.jpg\"><img src=https:\/\/semmelweis.hu\/pharmacology\/files\/2025\/10\/otka-fk-zf1-scaled.jpg  \r\n                            alt=\"\" \r\n                            class=\"attachment-sote-gallery-big size-sote-gallery-big\" \r\n                            srcset=\"https:\/\/semmelweis.hu\/pharmacology\/files\/2025\/10\/otka-fk-zf1-400x267.jpg 400w, https:\/\/semmelweis.hu\/pharmacology\/files\/2025\/10\/otka-fk-zf1-1024x683.jpg 1024w, https:\/\/semmelweis.hu\/pharmacology\/files\/2025\/10\/otka-fk-zf1-768x512.jpg 768w, https:\/\/semmelweis.hu\/pharmacology\/files\/2025\/10\/otka-fk-zf1-1536x1024.jpg 1536w, https:\/\/semmelweis.hu\/pharmacology\/files\/2025\/10\/otka-fk-zf1-2048x1365.jpg 2048w, https:\/\/semmelweis.hu\/pharmacology\/files\/2025\/10\/otka-fk-zf1-753x502.jpg 753w, https:\/\/semmelweis.hu\/pharmacology\/files\/2025\/10\/otka-fk-zf1-203x135.jpg 203w\" ><\/a><\/div>\r\n            <\/span>\r\n\r\n            <\/div>\r\n\r\n\t\t\t<div class=\"col-3 pl-0 pr-0\">\r\n\t\t\t\t<div class=\"galeria-right-img d-flex justify-content-between flex-column h-100 w-100 px-0 mx-0 \">\r\n                <div class=\"galeria-box\">\r\n\t\t\t\t\t<h3 class=\"galeria-title\">Gal\u00e9ria<\/h3>\r\n\t\t\t\t\t<div class=\"galeria-subtitle\">\r\n\r\n\t\t\t\t\t\t<div class=\"galeria-page-counter\"><span>4<\/span>k\u00e9p<\/div>\r\n                    <\/div> <\/div>\r\n                    <span class=\"gallery-item frame d-none d-md-flex\">\r\n\t\t\t\t\t<div class=\"galeria-small-img mt-0\"><a href=\"https:\/\/semmelweis.hu\/pharmacology\/files\/2025\/10\/otka-fk-zf2-scaled.jpg\"><img src=https:\/\/semmelweis.hu\/pharmacology\/files\/2025\/10\/otka-fk-zf2-scaled.jpg \r\n                                alt=\"\"  \r\n                                class=\"attachment-sote-gallery-small size-sote-gallery-small\" \r\n                                srcset=\"https:\/\/semmelweis.hu\/pharmacology\/files\/2025\/10\/otka-fk-zf2-400x267.jpg 400w, https:\/\/semmelweis.hu\/pharmacology\/files\/2025\/10\/otka-fk-zf2-1024x683.jpg 1024w, https:\/\/semmelweis.hu\/pharmacology\/files\/2025\/10\/otka-fk-zf2-768x512.jpg 768w, https:\/\/semmelweis.hu\/pharmacology\/files\/2025\/10\/otka-fk-zf2-1536x1024.jpg 1536w, https:\/\/semmelweis.hu\/pharmacology\/files\/2025\/10\/otka-fk-zf2-2048x1365.jpg 2048w, https:\/\/semmelweis.hu\/pharmacology\/files\/2025\/10\/otka-fk-zf2-753x502.jpg 753w, https:\/\/semmelweis.hu\/pharmacology\/files\/2025\/10\/otka-fk-zf2-203x135.jpg 203w\" ><\/a><\/div>\r\n                    <\/span>\r\n                    <span class=\"gallery-item frame d-none d-md-flex\">\r\n\t\t\t\t\t<div class=\"galeria-small-img mt-0\"><a href=\"https:\/\/semmelweis.hu\/pharmacology\/files\/2025\/10\/otka-fk-zf3-scaled.jpg\"><img src=https:\/\/semmelweis.hu\/pharmacology\/files\/2025\/10\/otka-fk-zf3-scaled.jpg \r\n                                alt=\"\" \r\n                                class=\"attachment-sote-gallery-small size-sote-gallery-small\" \r\n                                srcset=\"https:\/\/semmelweis.hu\/pharmacology\/files\/2025\/10\/otka-fk-zf3-400x267.jpg 400w, https:\/\/semmelweis.hu\/pharmacology\/files\/2025\/10\/otka-fk-zf3-1024x683.jpg 1024w, https:\/\/semmelweis.hu\/pharmacology\/files\/2025\/10\/otka-fk-zf3-768x512.jpg 768w, https:\/\/semmelweis.hu\/pharmacology\/files\/2025\/10\/otka-fk-zf3-1536x1024.jpg 1536w, https:\/\/semmelweis.hu\/pharmacology\/files\/2025\/10\/otka-fk-zf3-2048x1365.jpg 2048w, https:\/\/semmelweis.hu\/pharmacology\/files\/2025\/10\/otka-fk-zf3-753x502.jpg 753w, https:\/\/semmelweis.hu\/pharmacology\/files\/2025\/10\/otka-fk-zf3-203x135.jpg 203w\" ><\/a><\/div>\r\n                    <\/span>\r\n\r\n                <\/div>\r\n\r\n            <\/div>\r\n\r\n            <span class=\"gallery-item\"><div class=\"hidden\"><a href=\"https:\/\/semmelweis.hu\/pharmacology\/files\/2025\/10\/otka-fk-zf4-scaled.jpg\">\r\n        <img src=https:\/\/semmelweis.hu\/pharmacology\/files\/2025\/10\/otka-fk-zf4-scaled.jpg alt=\"\" class=\"attachment-sote-gallery-big size-sote-gallery-big\" srcset=\"https:\/\/semmelweis.hu\/pharmacology\/files\/2025\/10\/otka-fk-zf4-400x267.jpg 400w, https:\/\/semmelweis.hu\/pharmacology\/files\/2025\/10\/otka-fk-zf4-1024x683.jpg 1024w, https:\/\/semmelweis.hu\/pharmacology\/files\/2025\/10\/otka-fk-zf4-768x512.jpg 768w, https:\/\/semmelweis.hu\/pharmacology\/files\/2025\/10\/otka-fk-zf4-1536x1024.jpg 1536w, https:\/\/semmelweis.hu\/pharmacology\/files\/2025\/10\/otka-fk-zf4-2048x1365.jpg 2048w, https:\/\/semmelweis.hu\/pharmacology\/files\/2025\/10\/otka-fk-zf4-753x502.jpg 753w, https:\/\/semmelweis.hu\/pharmacology\/files\/2025\/10\/otka-fk-zf4-203x135.jpg 203w\" >\r\n        <\/a><\/div><\/span>\r\n            <\/div>\r\n\r\n            [\/slb_exclude]\r\n\t\n<p><strong>Mission and benefits<\/strong><\/p>\n<p>The main goal of this project is to identify targets for developing new drugs that could act as additional therapies to reduce the development of opioid analgesic tolerance. Opioid analgesic tolerance presents a significant challenge in clinical practice, as opioids can lose their effectiveness over time. This often leads to the necessity of increasing doses to achieve sufficient pain relief, which can worsen the intolerable side effects associated with these medications. Our research strategy is closely aligned with the university&#8217;s commitment to alleviating pain for patients. Additionally, by addressing this issue, our work can help to lessen the social burden associated with opioid use.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Exploring the role of the glycinergic system in the development of opioid analgesic tolerance \u00a0 Grant: OTKA-FK_ZF_2021 Amount of support: 39.942.000 HUF Duration: 2021. 09. 01. \u2013 2026. 04. 30. Principal investigator: Ferenc Z\u00e1dor, MD, PhD &nbsp; Summary Glycine transporters (GlyTs) 1 and 2 are involved in the regulation of synaptic glycine levels and are &hellip;<\/p>\n","protected":false},"author":102427,"featured_media":0,"parent":15124,"menu_order":12,"comment_status":"closed","ping_status":"closed","template":"","meta":{"_acf_changed":false,"footnotes":""},"categories":[],"tags":[],"class_list":["post-15253","page","type-page","status-publish","hentry"],"acf":[],"_links":{"self":[{"href":"https:\/\/semmelweis.hu\/pharmacology\/wp-json\/wp\/v2\/pages\/15253","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/semmelweis.hu\/pharmacology\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/semmelweis.hu\/pharmacology\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/semmelweis.hu\/pharmacology\/wp-json\/wp\/v2\/users\/102427"}],"replies":[{"embeddable":true,"href":"https:\/\/semmelweis.hu\/pharmacology\/wp-json\/wp\/v2\/comments?post=15253"}],"version-history":[{"count":1,"href":"https:\/\/semmelweis.hu\/pharmacology\/wp-json\/wp\/v2\/pages\/15253\/revisions"}],"predecessor-version":[{"id":15254,"href":"https:\/\/semmelweis.hu\/pharmacology\/wp-json\/wp\/v2\/pages\/15253\/revisions\/15254"}],"up":[{"embeddable":true,"href":"https:\/\/semmelweis.hu\/pharmacology\/wp-json\/wp\/v2\/pages\/15124"}],"wp:attachment":[{"href":"https:\/\/semmelweis.hu\/pharmacology\/wp-json\/wp\/v2\/media?parent=15253"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/semmelweis.hu\/pharmacology\/wp-json\/wp\/v2\/categories?post=15253"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/semmelweis.hu\/pharmacology\/wp-json\/wp\/v2\/tags?post=15253"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}